CD274 and neoplasm: In particular, the immune checkpoint receptor PD-1 is induced on activated T cells, and once bound to the ligands, PD-L1 or PD-L2, expressed on tumor cells or cells in the tumor microenvironment, reduces TCR signaling [18].